Parkinson’s
New artificial intelligence software can spot subtle movement changes in Parkinson's disease from video recordings before they are visible to clinicians. The technology analyses finger-tapping movements to find changes invisible to the human eye, potentially enabling earlier diagnosis and treatment. The AI system, called VisionMD, was developed by a team at the University of Florida [...]
A virus long thought to be harmless may play a role in Parkinson’s disease, new research suggests. Scientists at Northwestern Medicine detected Human Pegivirus (HPgV) in the brains and spinal fluid of people with Parkinson’s, but not in those without the condition. The virus appeared in half of the Parkinson’s brain samples examined but was [...]
UK-based NRG Therapeutics has raised US$67m (£50m) in series B financing to take its lead drug for Parkinson’s disease and ALS into first-in-human clinical trials. The fundraising round was led by the Dementia Discovery Fund, alongside the venture arms of Novartis and Merck KGaA. The series B funding will support Phase 1 trials of NRG5051, [...]
An ultrasound helmet that can target brain areas 1,000 times smaller than previous ultrasound methods may offer a non-invasive alternative to surgery for Parkinson’s disease. The device directs mechanical pulses to regions as small as a grain of rice in the brain, potentially replacing deep brain stimulation (DBS). DBS requires electrodes to be surgically implanted [...]
Neuro Rehab Times explores the latest developments in the world of neurology and neurorehabilitation. Gut immune system mouse model of Alzheimer’s provided new target for therapeutics The gut immune system is altered in a mouse model of Alzheimer’s, new research has found. The research shows that some immune cells in the gut travel along the [...]
New research may help explain what goes awry in the brains of people with Parkinson’s disease and could potentially lead to the development of new treatments. Researchers have long known that a particular subset of neurons die as Parkinson’s disease progresses, but they aren’t sure why. The new work shows that in mice, chronic activation [...]
Having a larger waistline, high blood pressure and other risk factors that make up metabolic syndrome is associated with an increased risk of Parkinson’s disease, according to a new study. The study does not prove that metabolic syndrome causes Parkinson’s disease; it only shows an association. Metabolic syndrome is defined as having three or more [...]
A low-oxygen environment, similar to air at Mount Everest base camp, could slow or even reverse Parkinson's symptoms, new research suggests, offering hope for new therapies. The study found that faulty cellular processes in the brain cause oxygen molecules to build up, damaging neurons and triggering symptoms. Restricting oxygen intake appeared to slow or even [...]
A new podcast series has been launched to help people with Parkinson's stay active. Get Active Stay Active, delivered by 1FitLife and Parkinson's UK, covers topics such as building up exercise intensity and choosing suitable footwear. The series brings together healthcare professionals, exercise experts and individuals living with Parkinson's to offer advice and guidance. [...]
In June, Cure Parkinson’s convened a workshop of researchers, organisations and individuals in the Parkinson’s community to focus on developing combination therapies. This informed the £2m funding call that the charity is announcing today that will open in October 2025. Currently, clinical trials for Parkinson’s have largely focussed on testing single drugs, or monotherapies, for [...]
